Health
Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform – Stockhead
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients….
Link copied toclipboard
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients, a sobering reminder of the dangers involved in cell therapy.
The patients reportedly died from immune…
Continue Reading
-
Business23 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News23 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General17 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General22 hours agoOlder Aussies back increased superannuation tax